Janux Therapeutics, Inc. (JANX) — DEF 14A Filings
All DEF 14A filings from Janux Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Janux Therapeutics DEF 14A: Executive Compensation Details
— Apr 25, 2025 Risk: medium
Janux Therapeutics, Inc. filed a DEF 14A on April 25, 2025, detailing executive compensation and equity awards for the fiscal years ending December 31, 2023, an -
Janux Therapeutics Files Definitive Proxy Statement
— Apr 29, 2024 Risk: low
Janux Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 29, 2024, for its annual meeting on June 26, 2024. The company, located in San
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX